[go: up one dir, main page]

PE20090373A1 - Envase - Google Patents

Envase

Info

Publication number
PE20090373A1
PE20090373A1 PE2008001005A PE2008001005A PE20090373A1 PE 20090373 A1 PE20090373 A1 PE 20090373A1 PE 2008001005 A PE2008001005 A PE 2008001005A PE 2008001005 A PE2008001005 A PE 2008001005A PE 20090373 A1 PE20090373 A1 PE 20090373A1
Authority
PE
Peru
Prior art keywords
layer
thick
aluminum
waterproof
caves
Prior art date
Application number
PE2008001005A
Other languages
English (en)
Inventor
Graham Cairns
John Alfred Davis
Neil Hyde
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PE20090373A1 publication Critical patent/PE20090373A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Abstract

SE REFIERE A UN ENVASE IMPERMEABLE AL AGUA Y AL OXIGENO TIPO BLISTER QUE ENCIERRA UNA ATMOSFERA INERTE DE GAS NITROGENO Y COMPRENDE UN LAMINADO DE ALUMINIO O ALUMINIO-PLASTICO, EN DONDE LA BASE QUE CONTIENE LAS CAVIDADES PARA LAS TABLETAS ES UNA HOJA QUE TIENE i) UNA CAPA DE POLIAMIDA ALIFATICA ENTRE 10um Y 40um DE ESPESOR; ii) LUEGO UNA CAPA METALICA ENTRE 30um Y 60um DE ESPESOR; Y iii) LUEGO LA CAPA QUE ES LA SUPERFICIE DE CONTACTO CON EL PRODUCTO ENTRE 40um Y 80um. DICHO ENVASE CONTIENE TABLETAS DE BUPRENORFINA QUE ADEMAS CONTIENEN LACTOSA, MANITOL, UN DESINTEGRANTE Y ESTEARATO DE MAGNESIO, NO SIENDO NECESARIA LA PRESENCIA DE UN ANTIOXIDANTE O UN AGENTE QUELANTE EN LA TABLETA PARA MEJORAR SU ESTABILIDAD
PE2008001005A 2007-06-13 2008-06-12 Envase PE20090373A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0711376A GB2450117A (en) 2007-06-13 2007-06-13 A water- and oxygen-occlusive blister tablet pack

Publications (1)

Publication Number Publication Date
PE20090373A1 true PE20090373A1 (es) 2009-04-01

Family

ID=38331999

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001005A PE20090373A1 (es) 2007-06-13 2008-06-12 Envase

Country Status (16)

Country Link
US (1) US8697718B2 (es)
EP (1) EP2155139B1 (es)
CN (1) CN101715337A (es)
AR (1) AR066975A1 (es)
AU (3) AU2008263682A1 (es)
BR (1) BRPI0812476A2 (es)
CA (1) CA2690036C (es)
CL (1) CL2008001744A1 (es)
ES (1) ES2626628T3 (es)
GB (1) GB2450117A (es)
MX (1) MX2009013535A (es)
NZ (1) NZ581604A (es)
PE (1) PE20090373A1 (es)
TW (1) TWI527579B (es)
WO (1) WO2008152347A2 (es)
ZA (1) ZA200908588B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056309T2 (hu) 2011-09-19 2022-02-28 Orexo Ab Buprenorfint és naloxont tartalmazó szublingvális, abúzus-rezisztens tabletták
CN108079221A (zh) * 2018-02-27 2018-05-29 湖南尔康制药股份有限公司 一种维c银翘泡腾片
CN108313367A (zh) * 2018-02-27 2018-07-24 湖南尔康制药股份有限公司 一种充惰性气体包装的维c银翘片

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549204A (en) * 1992-02-26 1996-08-27 Toren Consulting Pty. Ltd. Blister packs
US5432178A (en) * 1992-09-18 1995-07-11 Ono Pharmaceutical Co., Ltd. Amidinophenol derivatives
US5858490A (en) * 1993-06-10 1999-01-12 Nkk Corporation Film formed from polyethylene-2,6-naphthalate resin, process for producing said film and package using said film
CH689305A5 (de) * 1994-08-23 1999-02-15 Alusuisse Lonza Services Ag Blisterpackung.
US5799463A (en) * 1996-05-28 1998-09-01 Mitsubishi Gas Chemical Company, Inc. Method for preservation of article
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
CA2388123A1 (en) * 1999-10-23 2001-05-03 Sonja Joran Ugarkovic Oral dosage form comprising a salt of morphine or a morphine derivative
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US7025992B2 (en) * 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
SI21302A (sl) * 2002-10-11 2004-04-30 LEK farmacevtska dru�ba d.d. Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
WO2004064809A1 (en) * 2003-01-22 2004-08-05 Sandoz Ag Solid pharmaceutical composition comprising ramipril
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
WO2005074603A2 (en) * 2004-02-03 2005-08-18 Abbott Laboratories Aminobenzoxazoles as therapeutic agents
EP1750675B1 (en) * 2004-06-02 2008-10-29 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and salt thereof
BRPI0519561A2 (pt) * 2004-12-27 2009-01-27 King Pharmaceuticals Res & Dev composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
EP1772395B1 (de) * 2005-10-05 2011-03-09 Berlin-Chemie Ag Pharmazeutische Schutzverpackung
US8632801B2 (en) * 2005-12-28 2014-01-21 Alza Corporation Stable therapeutic formulations
WO2007084818A2 (en) * 2006-01-10 2007-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases

Also Published As

Publication number Publication date
TW200911217A (en) 2009-03-16
WO2008152347A3 (en) 2009-04-23
GB0711376D0 (en) 2007-07-25
US8697718B2 (en) 2014-04-15
US20100292265A1 (en) 2010-11-18
GB2450117A (en) 2008-12-17
CN101715337A (zh) 2010-05-26
CA2690036C (en) 2016-07-05
ES2626628T3 (es) 2017-07-25
BRPI0812476A2 (pt) 2014-12-02
CL2008001744A1 (es) 2009-05-22
AU2016203632A1 (en) 2016-06-23
MX2009013535A (es) 2010-02-22
TWI527579B (zh) 2016-04-01
CA2690036A1 (en) 2008-12-18
EP2155139A2 (en) 2010-02-24
AU2014203766A1 (en) 2014-07-31
WO2008152347A2 (en) 2008-12-18
AR066975A1 (es) 2009-09-23
ZA200908588B (en) 2011-02-23
AU2008263682A1 (en) 2008-12-18
AU2014203766B2 (en) 2016-06-09
NZ581604A (en) 2012-08-31
EP2155139B1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
ES2629749T3 (es) Inmunidad tumoral
BRPI0510010A (pt) vaso de pressão com camisa de proteção
CL2008002846A1 (es) Composicion de catalizador que comprende el producto del contacto entre un ansa-metaloceno y un activador; metodo para polimerizar olefinas; y ansa-metaloceno.
AR074424A2 (es) Un metodo para elaborar polvo de metal de titanio y polvo de titanio.
PE20000349A1 (es) Composicion farmaceutica que contiene una combinacion de una estatina y aspirina
WO2008156039A1 (ja) ブリスターパック形成用樹脂積層フィルムおよびブリスターパック
DE502007002695D1 (de) Retardtabletten mit Hydromorphon
PE20090373A1 (es) Envase
GB2428883B (en) Gravure plate, method for forming light-emitting layer or hole-injection layer using the same, and organic light-emitting device
AR058685A1 (es) Envase y composicion para otorgar propiedades mejoradas de barrera a los gases
MXPA05006627A (es) Sistema y metodo para una interfasa de usuario que proporciona el compartido de recursos a base de contacto.
CO6460711A2 (es) Composición y método de entrega
BR112013006228A2 (pt) dispositivo de acesso a um veículo a partir de uma plataforma
ES2628393T3 (es) Capa protectora antioxidante para materiales de TiAl y procedimiento para su producción
BRPI0520821A2 (pt) formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
Almblad et al. Erratum for Almblad et al., The cyclic AMP-Vfr signaling pathway in Pseudomonas aeruginosa is inhibited by cyclic di-GMP
ATE435381T1 (de) Leichtbau-tauchkolben
ES2484791T3 (es) Procedimiento para crear una capa inorgánica de cobertura sobre un producto de cobre o de una aleación de cobre
DE502006008431D1 (de) Transportträger, insbesondere Transportpalette
ATE390368T1 (de) Thermobehälter
SV2006002223A (es) Composicion farmaceutica ref. bhco41369-sv
DK1834895T3 (da) Emballage
ATE361801T1 (de) Transportbehälter
ITMO20040119A1 (it) Impianto per lo stoccaggio di preforme per la formatura di recipienti,particolarmente di bottiglie e simili.
ES1051122Y (es) Manometro perfeccionado para botellas contenedoras de agentes extintores.

Legal Events

Date Code Title Description
FC Refusal